NM_006279.5:c.1039-18C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_006279.5(ST3GAL3):c.1039-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.732 in 1,612,870 control chromosomes in the GnomAD database, including 446,591 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.60 ( 31732 hom., cov: 32)
Exomes 𝑓: 0.75 ( 414859 hom. )
Consequence
ST3GAL3
NM_006279.5 intron
NM_006279.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.239
Publications
24 publications found
Genes affected
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ST3GAL3 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 15Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- intellectual disability, autosomal recessive 12Inheritance: AR Classification: STRONG Submitted by: G2P
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.025).
BP6
Variant 1-43930114-C-T is Benign according to our data. Variant chr1-43930114-C-T is described in ClinVar as Benign. ClinVar VariationId is 262910.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ST3GAL3 | NM_006279.5 | c.1039-18C>T | intron_variant | Intron 11 of 11 | ENST00000347631.8 | NP_006270.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91210AN: 152006Hom.: 31729 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
91210
AN:
152006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.675 AC: 169443AN: 250916 AF XY: 0.686 show subpopulations
GnomAD2 exomes
AF:
AC:
169443
AN:
250916
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.745 AC: 1088861AN: 1460746Hom.: 414859 Cov.: 35 AF XY: 0.744 AC XY: 540573AN XY: 726778 show subpopulations
GnomAD4 exome
AF:
AC:
1088861
AN:
1460746
Hom.:
Cov.:
35
AF XY:
AC XY:
540573
AN XY:
726778
show subpopulations
African (AFR)
AF:
AC:
6833
AN:
33448
American (AMR)
AF:
AC:
26031
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
17885
AN:
26134
East Asian (EAS)
AF:
AC:
22464
AN:
39690
South Asian (SAS)
AF:
AC:
53626
AN:
86240
European-Finnish (FIN)
AF:
AC:
40424
AN:
53298
Middle Eastern (MID)
AF:
AC:
3520
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
875534
AN:
1111092
Other (OTH)
AF:
AC:
42544
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
14697
29395
44092
58790
73487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20370
40740
61110
81480
101850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.600 AC: 91236AN: 152124Hom.: 31732 Cov.: 32 AF XY: 0.598 AC XY: 44448AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
91236
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
44448
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
9625
AN:
41496
American (AMR)
AF:
AC:
9629
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
2362
AN:
3472
East Asian (EAS)
AF:
AC:
3209
AN:
5162
South Asian (SAS)
AF:
AC:
2942
AN:
4818
European-Finnish (FIN)
AF:
AC:
7931
AN:
10582
Middle Eastern (MID)
AF:
AC:
185
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53236
AN:
67994
Other (OTH)
AF:
AC:
1351
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1453
2906
4358
5811
7264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2080
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Intellectual disability, autosomal recessive 12 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Developmental and epileptic encephalopathy, 15 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.